← Back to Search

Genomic/Transcriptomic Analysis for Lymphoma

Q: What is the current sample size of this experiment?

<p>Yes, according to clinicaltrials.gov the trial that was initially launched on July 7th 2022 is currently recruiting patients. The last update was October 13th 2022 and up to 80 participants are needed from 1 site.</p>

Q: Is this research project actively seeking participants?

<p>Affirmative. Clinicaltrials.gov documents that this clinical trial is currently in the process of looking for participants, after being published on July 7th 2022 and most recently modified on October 13th 2022. 80 individuals need to be recruited from a single medical centre.</p>

N/A

Recruiting

Led By Jason Westin, MD

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion an average of 1 year

Awards & highlights

Study Summary

This trial is testing a commercial test to see if it helps guide care for people with lymphoma.

Who is the study for?

This trial is for adults over 18 with a confirmed diagnosis of diffuse large B-cell lymphoma that needs treatment. Participants must provide written consent to be part of the study.Check my eligibility

What is being tested?

The trial is examining the effectiveness of using a commercial test called Molecular Functional Portrait by BostonGene to guide treatment decisions in patients with lymphoma.See study design

What are the potential side effects?

Since this trial involves molecular testing and not drug intervention, there are no direct side effects from treatments like you would expect with medication or therapy.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion an average of 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion an average of 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Percentage of participants who have genomic test results available in <=7 days

Trial Design

1Treatment groups

Experimental Treatment

Group I: Molecular TestingExperimental Treatment1 Intervention

Molecular Functional (MF) Portrait (a commercial test conducted by the sponsor of this study, BostonGene) in guiding lymphoma care.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor

2,974 Previous Clinical Trials

1,789,396 Total Patients Enrolled

253 Trials studying Lymphoma

32,462 Patients Enrolled for Lymphoma

Jason Westin, MDPrincipal InvestigatorM.D. Anderson Cancer Center

3 Previous Clinical Trials

118 Total Patients Enrolled

3 Trials studying Lymphoma

118 Patients Enrolled for Lymphoma

Media Library

Molecular Testing Clinical Trial Eligibility Overview. Trial Name: NCT05464823 — N/A

Lymphoma Research Study Groups: Molecular Testing

Lymphoma Clinical Trial 2023: Molecular Testing Highlights & Side Effects. Trial Name: NCT05464823 — N/A

Molecular Testing 2023 Treatment Timeline for Medical Study. Trial Name: NCT05464823 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current sample size of this experiment?

"Yes, according to clinicaltrials.gov the trial that was initially launched on July 7th 2022 is currently recruiting patients. The last update was October 13th 2022 and up to 80 participants are needed from 1 site."

Answered by AI

Is this research project actively seeking participants?

"Affirmative. Clinicaltrials.gov documents that this clinical trial is currently in the process of looking for participants, after being published on July 7th 2022 and most recently modified on October 13th 2022. 80 individuals need to be recruited from a single medical centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Feasibility of Combined Genomics/Transcriptomics for Patients With Lymphoma

2022. "Feasibility of Combined Genomics/Transcriptomics for Patients With Lymphoma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05464823.